Interaction ID
ncRI-40651596
Interaction Molecules
hsa-miR-520a-3p -- NAPEPLD
Interaction Level
RNA-RNA
Interaction Class
binding
Data Source
TargetScan with Ago CLIP data
Tags
Organism
Homo sapiens
Tissue or Cell Type
T-REx-293T;HEK293S
Experiment
AGO CLIP
Description
Conserved miRNAs target sites predicted by TargetScan and miRanda overlap with the AGO CLIP dataset
Alias
-
Class
mRNA
Ensembl id
ENSG00000161048
Description
Hydrolyzes N-acyl-phosphatidylethanolamines (NAPEs) to produce N-acylethanolamines (NAEs) and phosphatidic acid (PubMed:25684574, PubMed:14634025, PubMed:16527816). Responsible for the generation of these bioactive fatty acid ethanolamides (FAEs), including anandamide (N-arachidonoylethanolamine), the ligand of cannabinoid and vanilloid receptors (PubMed:14634025). As a regulator of lipid metabolism in the adipose tissue, mediates the crosstalk between adipocytes, gut microbiota and immune cells to control body temperature and weight. In particular, regulates energy homeostasis by promoting cold-induced brown or beige adipocyte differentiation program to generate heat from fatty acids and glucose (By similarity).
Pubmed ID | 23824327 | Journal | Genes & development |
---|---|---|---|
Title | Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. | ||
Author | Karginov FV, Hannon GJ |
Pubmed ID | 29273203 | Journal | Journal of molecular biology |
---|---|---|---|
Title | Transcriptome-wide Identification and Validation of Interactions between the miRNA Machinery and HuR on mRNA Targets. | ||
Author | Li Y, Estep JA, Karginov FV |
Molecule | Disease | Data Source |
---|---|---|
hsa-miR-520a-3p | adenocarcinoma | MNDR Database |
hsa-miR-520a-3p | adenoma | MNDR Database |
hsa-miR-520a-3p | Alzheimer's disease | MNDR Database |
hsa-miR-520a-3p | amyotrophic lateral sclerosis | MNDR Database |
hsa-miR-520a-3p | arthritis | MNDR Database |
hsa-miR-520a-3p | asthma | MNDR Database |
hsa-miR-520a-3p | atherosclerosis | MNDR Database |
hsa-miR-520a-3p | autosomal recessive disease | MNDR Database |
hsa-miR-520a-3p | bone disease | MNDR Database |
hsa-miR-520a-3p | brain disease | MNDR Database |
hsa-miR-520a-3p | breast cancer | MNDR Database |
hsa-miR-520a-3p | Breast Neoplasms | MNDR Database |
hsa-miR-520a-3p | cancer | MNDR Database |
hsa-miR-520a-3p | carcinoma | MNDR Database |
hsa-miR-520a-3p | Carcinoma, Non-Small-Cell Lung | MNDR Database |
hsa-miR-520a-3p | cholangiocarcinoma | MNDR Database |
hsa-miR-520a-3p | colorectal cancer | MNDR Database |
hsa-miR-520a-3p | diabetes mellitus | MNDR Database |
hsa-miR-520a-3p | embryonal cancer | MNDR Database |
hsa-miR-520a-3p | endometriosis | MNDR Database |
hsa-miR-520a-3p | eye disease | MNDR Database |
hsa-miR-520a-3p | familiar ovarian carcinoma | MNDR Database |
hsa-miR-520a-3p | Fetal Growth Retardation | MNDR Database |
hsa-miR-520a-3p | gout | MNDR Database |
hsa-miR-520a-3p | heart disease | MNDR Database |
hsa-miR-520a-3p | Heart Failure | MNDR Database |
hsa-miR-520a-3p | hepatocellular carcinoma | MNDR Database |
hsa-miR-520a-3p | Her2-receptor positive breast cancer | MNDR Database |
hsa-miR-520a-3p | Hodgkin's lymphoma | MNDR Database |
hsa-miR-520a-3p | hypersensitivity reaction type II disease | MNDR Database |
hsa-miR-520a-3p | hypertension | MNDR Database |
hsa-miR-520a-3p | intellectual disability | MNDR Database |
hsa-miR-520a-3p | kidney disease | MNDR Database |
hsa-miR-520a-3p | leukemia | MNDR Database |
hsa-miR-520a-3p | liposarcoma | MNDR Database |
hsa-miR-520a-3p | liver disease | MNDR Database |
hsa-miR-520a-3p | lung cancer | MNDR Database |
hsa-miR-520a-3p | lung disease | MNDR Database |
hsa-miR-520a-3p | lung squamous cell carcinoma | MNDR Database |
hsa-miR-520a-3p | lymphoma | MNDR Database |
hsa-miR-520a-3p | malignant glioma | MNDR Database |
hsa-miR-520a-3p | melanoma | MNDR Database |
hsa-miR-520a-3p | Multiple Sclerosis, Chronic Progressive | MNDR Database |
hsa-miR-520a-3p | myocardial infarction | MNDR Database |
hsa-miR-520a-3p | myopathy | MNDR Database |
hsa-miR-520a-3p | nasopharynx carcinoma | MNDR Database |
hsa-miR-520a-3p | nephroblastoma | MNDR Database |
hsa-miR-520a-3p | neurodegenerative disease | MNDR Database |
hsa-miR-520a-3p | pancreatic adenocarcinoma | MNDR Database |
hsa-miR-520a-3p | pancreatic cancer | MNDR Database |
hsa-miR-520a-3p | pancreatic ductal adenocarcinoma | MNDR Database |
hsa-miR-520a-3p | pre-eclampsia | MNDR Database |
hsa-miR-520a-3p | progesterone-receptor negative breast cancer | MNDR Database |
hsa-miR-520a-3p | progesterone-receptor positive breast cancer | MNDR Database |
hsa-miR-520a-3p | relapsing-remitting multiple sclerosis | MNDR Database |
hsa-miR-520a-3p | retinal degeneration | MNDR Database |
hsa-miR-520a-3p | skin disease | MNDR Database |
hsa-miR-520a-3p | squamous cell carcinoma | MNDR Database |
hsa-miR-520a-3p | stomach cancer | MNDR Database |
hsa-miR-520a-3p | tonsil cancer | MNDR Database |
hsa-miR-520a-3p | vascular disease | MNDR Database |